Rivastigmine - NDC Database (Page 6)

110 records found
Page:First PagePrevious Page6
72241-012 Oct 05, 2021
Rivastigmine Tartrate 3 mg Oral Capsule by Modavar Pharmaceuticals LLC
72241-013 Oct 05, 2021
Rivastigmine Tartrate 4.5 mg Oral Capsule by Modavar Pharmaceuticals LLC
72241-014 Oct 05, 2021
Rivastigmine Tartrate 6 mg Oral Capsule by Modavar Pharmaceuticals LLC
72855-100 Dec 19, 2019
Rivastigmine Transdermal System Transdermal System 4.6 mg/24h Transdermal Patch, Extended Release by Adhexpharma
72855-101 Dec 19, 2019
Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Adhexpharma
72855-102 Dec 19, 2019
Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Adhexpharma
75834-133 Sep 04, 2017
Rivastigmine Tartrate 1.5 mg Oral Capsule by Nivagen Pharmaceuticals, Inc.
75834-134 Sep 04, 2017
Rivastigmine Tartrate 3 mg Oral Capsule by Nivagen Pharmaceuticals, Inc.
75834-135 Sep 04, 2017
Rivastigmine Tartrate 4.5 mg Oral Capsule by Nivagen Pharmaceuticals, Inc.
75834-136 Sep 04, 2017
Rivastigmine Tartrate 6 mg Oral Capsule by Nivagen Pharmaceuticals, Inc.
Page:First PagePrevious Page6
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.